Related Experiment Videos

[Correlation between serum lipid level and coronary bed lesions in patients with ischemic heart disease]

Kardiologiia
|November 1, 1984
PubMed

Insights

Total cholesterol and low-density lipoprotein cholesterol levels directly correlate with coronary atherosclerosis severity in heart disease patients. High-density lipoprotein cholesterol changes are unreliable indicators for assessing coronary artery disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Medical Diagnostics

Context:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Accurate assessment of atherosclerotic damage is crucial for effective CHD management.
  • Blood lipid profiles are commonly analyzed as potential indicators of cardiovascular risk.

Purpose:

  • To investigate the correlation between specific blood lipid levels and the extent of atherosclerotic damage in the coronary arteries of patients with established coronary heart disease.
  • To determine the diagnostic value of various lipid parameters in assessing the severity of coronary atherosclerosis.

Summary:

  • This study analyzed blood lipid levels in 124 patients with coronary heart disease (CHD).
  • A significant positive correlation was observed between elevated total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and the degree of coronary atherosclerotic lesions.
  • Conversely, high-density lipoprotein cholesterol (HDL-C), very low-density lipoprotein cholesterol (VLDL-C), and the atherogenicity index showed no significant correlation with the severity of coronary atherosclerosis. A trend towards increased triglyceride levels was noted.
  • The findings suggest that total cholesterol and LDL-C are reliable indicators for evaluating CHD severity.

Impact:

  • Recommends focusing on total cholesterol and LDL-C measurements for assessing coronary atherosclerosis severity in clinical practice.
  • Highlights the limited utility of HDL-C and other lipid parameters in quantifying the extent of coronary artery disease.
  • Informs clinical guidelines for CHD risk stratification and patient management by identifying key lipid biomarkers.

Related Concept Videos